Medtronic plc
MDT
株式のランク
#184
Medtronic plc is a leading global medical technology enterprise that invents,... Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.
株価
$94.59
最終同期: 2026-10-20
時価総額
$120.99B
変化（1日）
1.76%
変化（1年）
-1.30%
国
IE
取引 Medtronic plc (MDT)
カテゴリー
Healthcare
Medtronic plc（MDT）の収益
Jan 2026 時点の収益 TTM: $35.48B
Medtronic plc の最新の財務報告によると、現在の収益 (TTM) は $35.48B です。2024 年には $32.36B の収益があり、これは 2023 年の $31.23B と比較して 増加 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Medtronic plc の収益履歴（2000 ～ 2026）
各年末の収益
| 年 | 収益 | 変化 |
|---|---|---|
| 2026 (TTM) | $35.48B | 5.81% |
| 2025 | $33.54B | 3.62% |
| 2024 | $32.36B | 3.64% |
| 2023 | $31.23B | -1.45% |
| 2022 | $31.69B | 5.21% |
| 2021 | $30.12B | 4.16% |
| 2020 | $28.91B | -5.38% |
| 2019 | $30.56B | 2.02% |
| 2018 | $29.95B | 0.82% |
| 2017 | $29.71B | 3.04% |
| 2016 | $28.83B | 42.31% |
| 2015 | $20.26B | 19.15% |
| 2014 | $17.01B | 2.50% |
| 2013 | $16.59B | 2.51% |
| 2012 | $16.18B | 1.58% |
| 2011 | $15.93B | 0.73% |
| 2010 | $15.82B | 8.34% |
| 2009 | $14.60B | 8.02% |
| 2008 | $13.52B | 9.89% |
| 2007 | $12.30B | 8.92% |
| 2006 | $11.29B | 12.31% |
| 2005 | $10.05B | 10.65% |
| 2004 | $9.09B | 18.55% |
| 2003 | $7.67B | 19.57% |
| 2002 | $6.41B | 15.47% |
| 2001 | $5.55B | 10.71% |
| 2000 | $5.01B | 0.00% |
同業他社の収益
| 企業 | 収益 | 収益の差 | 国 |
|---|---|---|---|
| $46.59B | 31.28% |
US
|
|
| $25.84B | -27.19% |
US
|
|
| $21.00B | -40.83% |
US
|
|
| - | - |
DE
|
|
| $6.51B | -81.65% |
US
|
